Key Financial Data Of Group

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7310818

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
Key financial data of group
Business results of group
Net sales
2,860,000,000 JPY
6,120,000,000 JPY
2,488,000,000 JPY
Ordinary profit (loss)
528,000,000 JPY
-1,248,000,000 JPY
-510,000,000 JPY
Profit (loss) attributable to owners of parent
764,000,000 JPY
-3,611,000,000 JPY
-514,000,000 JPY
Comprehensive income
1,257,000,000 JPY
-3,466,000,000 JPY
-334,000,000 JPY
Net assets
8,074,000,000 JPY
6,739,000,000 JPY
9,177,000,000 JPY
Total assets
13,383,000,000 JPY
13,220,000,000 JPY
15,636,000,000 JPY
Basic earnings (loss) per share
15.24
-76.25
-11.36
Diluted earnings per share
Equity-to-asset ratio
0.603 xbrli:pure
0.510 xbrli:pure
0.587 xbrli:pure
Net cash provided by (used in) operating activities
256,000,000 JPY
-307,000,000 JPY
126,000,000 JPY
Net cash provided by (used in) investing activities
-135,000,000 JPY
1,166,000,000 JPY
707,000,000 JPY
Net cash provided by (used in) financing activities
-562,000,000 JPY
1,539,000,000 JPY
827,000,000 JPY
Cash and cash equivalents
4,916,000,000 JPY
5,244,000,000 JPY
4,511,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.